GrantPostedDiscretionary

Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)

National Institutes of Health
RFA-DK-26-007
Application Deadline
Mar 8, 2026
Closed
Days Remaining
0
Deadline passed
Award Ceiling
Total Program Funding

Grant Opportunity Analysis

The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for collaborative research projects focused on type 1 diabetes, specifically utilizing biosamples and data from established clinical studies. The objective is to advance the understanding of the disease's etiology and pathogenesis, with funding available for studies that aim to explore disease mechanisms, delay onset, and improve prevention strategies. A total of $5.5 million is committed for up to four awards in Fiscal Years 2026 and 2027, with application deadlines beginning on May 26, 2025, and a final submission date of March 9, 2026. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.

Eligible Applicants

Others
Additional Eligibility Information

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Grant Documents

1 Files
RFA-DK-26-007.html
HTML128 KB1/18/2025
AI Summary
The National Institutes of Health (NIH) has issued a Notice of Funding Opportunity (NOFO) for research projects focused on type 1 diabetes, particularly using biosamples and data from established clinical studies. This funding, under the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), aims to advance understanding of the disease's etiology and pathogenesis through collaborative research. Applicants can request funding to study disease mechanisms, delaying onset, and improving prevention strategies, with a total commitment of $5.5 million available for up to four awards in both Fiscal Year 2026 and 2027. Important application requirements include adherence to specific submission guidelines, registration with relevant agencies, and the inclusion of a Plan for Enhancing Diverse Perspectives (PEDP) to foster inclusivity in research teams. Projects must use existing clinical data and biosamples approved by NIDDK and comply with NIH data-sharing policies. Eligible applicants include various education institutions, nonprofit organizations, and government entities, and applications will undergo rigorous scientific review to ensure merit. The proposal submission deadlines begin on May 26, 2025, with an expiration date set for March 9, 2026, making it essential for interested parties to prepare early.

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedJan 15, 2025
deadlineApplication DeadlineMar 8, 2026
expiryArchive DateApr 13, 2026

Funding Details

No cost sharing required

Agency & Classification

Agency
National Institutes of Health(HHS-NIH11)
Funding Category
Health
Funding Instrument
Grant

Grantor Contact

CFDA Numbers

93.847

Official Sources